Novel Antischizophrenia Treatments / edited by Mark A. Geyer, Gerhard Gross
(Handbook of Experimental Pharmacology ; 213)
データ種別 | 電子ブック |
---|---|
著者標目 | *Geyer, Mark A. Gross, Gerhard SpringerLink (Online service) |
出版情報 | Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer , 2012 |
書誌詳細を非表示
巻次 | ISBN:9783642257582 |
---|---|
大きさ | X, 455 p. 20 illus., 15 illus. in color : digital |
内容注記 | Preface Clinical instruments to evaluate and guide treatment in schizophrenia Cognitive deficits in schizophrenia- Muscarinic mechanisms in psychotic disorders Nicotinic mechanisms in psychotic disorders GABAergic circuits in schizophrenia: targets for new treatments in schizophrenia Inhibitors of glycine transport as potential new treatments in schizophrenia The role of glutamate in schizophrenia Metabotropic glutamate receptors as targets for new treatments in schizophrenia 5-HT2C agonism as a principle for new treatments in schizophrenia.- The role of dopamine D3 receptors for antipsychotic activity and cognitive functions Phosphodiesterase inhibitors as potential new treatments in schizophrenia Disease modifying approaches to schizophrenia A novel therapeutic strategy: medication-enhancement of cognitive therapies in schizophrenia Transgenic animals reflecting aspects of schizophrenia Behavioral animal models of pro-cognitive treatments for schizophrenia. |
件 名 | LCSH:Medicine LCSH:Toxicology LCSH:Pharmacy LCSH:Psychopharmacology LCSH:Applied psychology FREE:Biomedicine FREE:Pharmacology/Toxicology FREE:Pharmacy FREE:Psychopharmacology FREE:Biological Psychology |
分 類 | DC23:615 |
書誌ID | OB00006484 |
ISBN | 9783642257582 |
NCID | LB40010154 |